Retatrutide is a triple agonist targeting GLP-1, GIP and glucagon receptors, developed for the management of obesity and significant weight reduction. Administered by subcutaneous injection, it combines anorexigenic effects, improved insulin sensitivity and increased energy metabolism. Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity.
⚠️Important note
Each product must be mixed with bacteriostatic water. A Free 3ml bottle is included with every purchase.
